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Abstract
Aim: To compare metabolic effects and oxidative stress
in pregnant and non-pregnant women after 12 h of
fasting.
Methods: Twenty-six healthy women with uncomplicated
singleton pregnancies between the 24th and 28th gesta-
tional week were recruited. After an overnight fast,
venous blood samples and urine samples were tested for
metabolic parameters characteristic for starvation, corti-
sol and oxidative stress products. Healthy non-pregnant
women matched by age, body mass index and length of
fasting comprised the control group.
Results: The metabolic parameters b-hydroxybutyrate
and free fatty acids in blood and ketones in urine showed
no differences in pregnant and non-pregnant women.
However, the oxidative stress parameters, 8,12-iso-iPF2a-
VI, isoprostanes and malondialdehyde were signifi-
cantly higher in pregnant subjects, as was cortisol.
Conclusion: Healthy pregnant women are exposed to
oxidative stress and activation of the hypothalamo-pitu-
itary-adrenal axis, but not to metabolic changes resem-
bling starvation during short fasting periods in
comparison to non-pregnant healthy women.
Keywords: Fetal programming; isoprostanes; malondial-
dehyde; oxidative stress; pregnancy.
Introduction
Normal pregnancy is associated with a systemic inflam-
matory response. Acute phase reactants and inflamma-
tory leukocytes are elevated, and both endothelial cells
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and thrombocytes are activated. Some of the metabolic
changes during normal pregnancy have similarities with
the metabolic syndrome which includes hyperlipidemia,
insulin resistance and the activation of the clotting sys-
tem w12, 17x. Both systemic inflammation and the tran-
sient change into the metabolic syndrome in pregnancy
were considered to be potential risk factors for both
mother and fetus w19x. This view is supported by two
important studies, the Framingham Heart Study and the
National Health and Nutrition Examination Survey Nation-
al Epidemiologic Follow-up Study (NHEFS) w9x, where the
rates of coronary heart disease were higher among multi-
gravid women than among women who had never been
pregnant.
Systemic inflammation is believed to be a physiological
response towards ‘‘danger signals’’ within the organism.
One possible explanation for inflammation in normal
pregnancy is an increased level of oxidative stress. Oxi-
dative stress is defined as an imbalance between free
radical damage and antioxidant protection, caused by
the presence of free radicals or radical-generating agents
in concentrations that overwhelm natural radical-blocking
or -scavenging mechanisms. Oxidative stress induces
oxidative damage to biological substances such as lip-
ids, DNA and proteins w3x and may be responsible for
adverse changes in the unborn baby and thereby for
effects of fetal programming and – in the long-term – for
atherosclerosis and cardiovascular disease in the mother.
Cardiovascular health can also be influenced by poor or
unbalanced nutrition, increased urinary nitrogen excre-
tion, increased plasma and urinary ketones and raised
plasma levels of free fatty acids, the latter acting as a
pro-oxidant substance. It is unclear whether the adverse
effect of pregnancy (at least multiparity) on maternal car-
diovascular health is the result of oxidative stress, acti-
vation of the HPA (hypothalamo-pituitary-adrenal)-axis,
metabolic changes resembling starvation (catabolism) or
a mixture thereof. We, therefore, examined whether preg-
nant women matched by age, body mass index (BMI)
and duration of fasting are exposed to oxidative stress,
activation of the HPA-axis and/or catabolic metabolism
in comparison to non-pregnant women.
Materials and methods
A total of 27 healthy volunteers with uncomplicated singleton
pregnancies between the 24th and 28th gestational week were
recruited from the Department of Obstetrics at the University
Hospital of Zurich in association with a routine fasting glucose
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Table 1 Fasting duration, age, BMI, gestational and ethnical characteristics of the tested women.
Pregnant (ns26) Non-pregnant (ns26) P
Fasting time (h) 11.76"3.07 11.84"2.96 NS (0.80)
Age (years) 28.35"4.73 27.58"4.98 NS (0.67)
BMI 22.57"3.43 22.13"3.34 NS (0.58)
Gestational week 26.19"0.97 – –
Parity 1.73"0.78 0.19"0.69 S (-0.0001)
Caucasian 19 26
Asian 4 – NS
Afro-Caribbean 1 –
Oriental 2 –
Mean"SD; P, denotes significance (-0.05) between pregnant and non-pregnant.
control. The same number of healthy non-pregnant women
matched by age group, BMI and length of fasting were recruited
as a controls from the employees of the University Hospital. The
non-pregnant controls were advised to fast for exactly the same
time as their pregnant match. One pregnant woman was exclu-
ded from the study because gestational diabetes was diag-
nosed. Hence a total of 26 women were in each group, which
allows a statistically significant interpretation of the results. Both
the pregnant and the non-pregnant participants of the study
were in good general health and had no disease or problems
with their carbohydrate metabolism. Aside from standard pre-
natal vitamins or iron supplements they were not taking any
medication. Each of the pregnant women gave birth to a healthy
child. All volunteers gave written informed consent to participate
in this study. The participation to this study was not financially
rewarded.
To calculate the BMI of the pregnant women we used the pre-
gravid weight. For randomization, we divided the women into
four age- (16–20, 21–30, 31–40 and 41–45 years) and BMI
groups (-20 underweight, 20–24.9 normal, 25–29.9 overweight,
30–39.9 obese). Age was calculated in completed years, where-
as gestational age was measured accurate to a day. Gestational
age was determined by the last menstrual period and corrected
with early ultrasound, if necessary. Further details are given in
Table 1.
Following an overnight fast, 25 mL of venous blood was taken
and tested for free fatty acids (FFA), b-hydroxybutyrate, cortisol/
insulin-ratio and malondialdehyde. In addition, the subjects gave
a morning urine sample which was used to measure ketones,
creatinine, isoprostanes and 8,12-iso-iPF2a-VI. The same blood
and urine samples were taken from non-pregnant controls at the
same time in the morning after fasting overnight and skipping
breakfast.
The study protocol was approved by the local Ethical Com-
mittee of the University of Zurich/Switzerland.
As oxidative stress markers we used malondialdehyde (MDA)
in blood serum and 8,12-iso-iPF2a-VI and isoprostanes in urine
corrected for creatinine. Markers for the metabolic status were
cortisol/insulin ratio, serum-glucose, free fatty acids (FFA) and
b-hydroxybutyrate. The blood samples were processed and fro-
zen at –208C just after blood withdrawal and the urine samples
just after collection, to avoid auto-oxidation or other processes
that may have changed the concentration of the measured
parameters.
All markers except MDA, isoprostanes and 8,12-iso-iPF2a-VI
were measured at the Institute for Clinical Chemistry, University
Hospital in Zurich.
Basal cortisol was determined in heparinized plasma by an
electrochemiluminescence assay. b-hydroxybutyrate was meas-
ured by an enzymatic rate method with the use of b-hydroxy-
butyrate dehydrogenase. FFA in serum was determined by an
enzymatic colorimetric-test and insulin with chemiluminescence
assays. For the analysis of MDA, EDTA blood was separated by
centrifugation at 48C immediately after blood-withdrawal. The
separated plasma samples were frozen and stored at –208C until
analysis in the research laboratory of the Department of Obstet-
rics of the Zurich University Hospital using the Lipid Peroxidation
Assay Kit from Calbiochem (Cat No 437634, Merck Biosciences,
Darmstadt, Germany). The principle of this colorimetric assay is
the reaction of a chromogenic reagent with MDA at 458C. One
molecule of MDA condensates with two molecules of the rea-
gent to yield a stable chromophore with a maximal absorbance
at 586 nm. Isoprostanes were analyzed in urine samples that
were frozen at –808C in the Department of Pediatrics at Philipps-
University Marburg, Germany. The samples were processed as
follows: Urine (100 mL) was diluted with 200 mL water and tetra-
deuterated w2H4x-PGF2a (1 ng in 10 mL ethyl acetate) was added.
After acidification with formic acid to pH 2.5, the prostanoids
were extracted twice with 1 mL ethyl acetate-hexane (70:30,
v/v). After evaporation of the solvent, acetone (80 mL), N,N-di-
isopropylethylamine (7 mL) and pentafluorobenzyl bromide
(6 mL) were added. The mixture was allowed to react at 408C
for 25 min. The dry sample was purified by thin layer chroma-
tography (TLC, developing solvent: ethyl acetate-hexane 90:10,
v/v). A broad zone (RF 0.03–0.39) was eluted with the TLC devel-
oping solvent (1 mL) and water (50 mL) was added. After cen-
trifugation, the ethyl acetate phase was withdrawn, the solvent
was evaporated and the prostanoids derived with BSTFA: N,O-
bis(trimethylsilyl)trifluoro acetamide (10 mL; 408C, 1 h). A 1 mL
aliquot of this solution was injected.
For the analysis of 8,12-iso-iPF2a-VI urine (1 mL) and w2H11x-
8,12-iso-iPF2a-VI (1 ng) were acidified with formic acid to pH 2.5
and the prostanoids were extracted twice with 3 mL of ethyl
acetate-hexane (70:30, v/v). After evaporation of the solvent,
acetonitrile (80 mL), pentafluorobenzyl bromide (7 mL) and N,N-
diisopropylethylamine (25 mL) were added. The mixture was
allowed to react at 408C for 25 min. The dry sample was purified
by TLC (developing solvent: ethyl acetate-methanol 100:3, v/v).
The zone with an RF 0.2–0.33 was eluted with TLC ethylacetate
(800 mL) and water (50 mL) was added. Further sample prepa-
ration was as described for the isoprostanes.
The concentration of each parameter in the prepared urine
samples was determined using gas chromatography/tandem
mass spectrometry (GC/MS/MS). A Finnigan MAT TSQ700 tan-
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Figure 1 Cortisol serum levels after having skipped breakfast.
Pregnant women during their second trimester have significantly
elevated cortisol levels compared to non-pregnant women.
Circlesspregnant, pyramidsscontrols, continuous linesmedi-
an of pregnant, dashed linesmedian of controls.
Table 2 Duration of fasting and concentration of parameters after ‘‘skipped breakfast’’.
Pregnant (ns26) Non-pregnant (ns26) P
Glucose (mmol/L) 4.32"0.31 4.50"0.33 NS (0.07)
b-hydroxybutyrate (mmol/L) 171.81"86.35 189.81"73.72 NS (0.13)
FFA (mmol/L) 391.42"153.21 465.89"254.81 NS (0.55)
Cortisol (nmol/L) 813"178.28 538.69"291.61 S (0.0002)
Insulin (mIU/L) 6.92"5.05 4.81"4.22 NS (0.062)
C/I-ratio (103) 28.13"22.77 24.51"20.93 NS (0.37)
Malondialdehyde (mmol/L) 4.52"0.77 2.88"0.52 S (-0.0001)
8,12-iso-iPF2a-VI (ng/mg)* 13.69"6.46 8.31"5.05 S (0.0008)
Isoprostanes (ng/mg)* 78.15"23.72 59.92"40.77 S (-0.0001)
Mean"SD; P, denotes significance (-0.05) between pregnant and non-pregnant. *Corrected for creatinine.
dem mass spectrometer equipped with a Varian 3400 gas chro-
matograph and a CTC A200S autosampler (Finnigan MAT,
Bremen, Germany) was employed. Gas chromatography of
prostanoid derivatives was carried out on J&W DB-1
(15 m=0.25 mm I.D., 0.25 mm film thickness) capillary column
(MasCom, Bremen, Germany) in the splitless mode at an inlet
pressure of 100 kPa. The oven temperature program for all pros-
tanoids analyzed was as follows: an initial temperature of 1008C
was held for 2 min, and then increased at 308/min to 2808C and
at 58/min to 3108C. This temperature was held for 2 min. The
mass spectrometer conditions were: interface temperature
3008C, source temperature 1508C, methane CI gas pressure
50 Pa, electron energy 70 eV, emission current 0.4 mA, conver-
sion dynode 15 kV, electron multiplier 2000 V and the collision
cell pressure was 0.2 Pa. For the isoprostanes the collision ener-
gy was 12 eV and the daughter ions used for quantificationwere
wP – 3 (CH3)3SiOHx- (m/z 569.3™ m/z 299.3 for the endogenous
isoprostanes, m/z 573.3 ™ m/z 303.2 for the tetradeuterated
internal standard). For 8,12-iso-iPF2a-VI the parent ions of the
characteristic fragment C6H7O2- (m/z 111.0) were used: m/z
569.3 for the endogenous 8,12-iso-iPF2a-VI and m/z 580.4 for
the deuterated internal standard. Collision energy was 28 eV. The
urinary 8,12-iso-iPF2a-VI and isoprostane levels were corrected
for creatinine values to eliminate influences of renal function on
the result.
Statistical difference between the two groups was determined
by Mann-Whitney U-Test. We used StatView for Windows, ver-
sion 5.0.1 (SAS Institute Inc. Copyright,  1992–1998,
www.statview.com). A P-value -0.05 was considered statisti-
cally significant. The graphical data are presented with scatter-
plots and median values.
Results
The groups were similar regarding fasting time, BMI, and
age (Table 1). The concentrations of circulating oxidative
and metabolic parameters are summarized in Table 2.
The women’s individual BMI did not correlate with the
measured concentration of oxidative stress products.
Regarding cortisol, we found a slight, but not a significant
increase with greater BMI in pregnant women. No signi-
ficant correlation was observed for non-pregnant
subjects.
Metabolic parameters: Serum-insulin tended to be
higher in pregnant women, but the difference did not
reach significance (Table 2). All of the metabolic para-
meters (serum-glucose, free fatty acids (FFA), b-hydroxy-
butyrate and the cortisol/insulin-ratio) were not significant
(Table 2).
HPA-axis: We observed a significant elevation of cor-
tisol in pregnant subjects (Ps0.0002) compared to non-
pregnant subjects (Figure 1).
Oxidative stress parameters: The tested oxidative
stress parameters, namely isoprostanes (P-0.0001),
8,12-iso-iPF2a-VI (Ps0.0008) (Figure 2), and malondial-
dehyde (P-0.0001) (Figure 3), were significantly elevated
in pregnant women.
Comment
We could show that after a short starvation, all of our
tested parameters of oxidative stress as well as serum
cortisol levels were significantly elevated in pregnant
women in the late second trimester in comparison to
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Figure 2 8,12-iso-iPF2a-VI levels in urine after fasting. Pregnant
women have significantly elevated levels, which is due to the
greater oxidative stress.
Circlesspregnant, pyramidsscontrols, continuous linesmedi-
an of pregnant, dashed linesmedian of controls.
Figure 3 Malondialdehyde concentration in serum after having skipped breakfast. Pregnant women having significantly elevated
malondialdehyde levels compared to non-pregnant women.
Circlesspregnant, pyramidsscontrols, continuous linesmedian of pregnant, dashed linesmedian of controls.
healthy non-pregnant controls. Metabolic parameters
indicative of catabolism, however, were not altered.
The level of oxidative stress may vary considerably
throughout day and night and depends on the interval
since the last food intake. This might be the reason for
the conflicting results in the literature regarding the
occurrence of oxidative stress in normal pregnancy and
in preeclampsia w4, 7, 15x. Consequently, the metabolic
parameters of catabolism and plasma levels of cortisol
vary significantly if they are not measured under standard
conditions. The measurements in our study were con-
ducted in a healthy pregnant population matched with
the non-pregnant controls for BMI, age and period of
fasting. Moreover, serum malondialdehyde and 8,12-iso-
iPF2a-VI and isoprostanes in urine corrected for creatinine
are the most reliable markers for oxidative stress w2, 15,
16x. We measured oxidative stress, cortisol and the
metabolic parameters the morning after an overnight
fast, because this interval allows for standardized meas-
urements and represents a common metabolic situation
occurring in many pregnant women who decide to skip
breakfast due to personal preference, work overload, or
for laboratory testing. Therefore, we believe that our
results truly reflect increased oxidative stress and an acti-
vation of the HPA-axis in pregnant women in comparison
to non-pregnant women under physiological conditions.
It is well known that both oxidative stress and
increased plasma cortisol levels are risk factors for athero-
sclerosis and cardiovascular disease w22x. Interestingly,
women having six or more pregnancies show a consis-
tently increased risk of coronary heart and cardiovascular
disease w9x. However, the same tendency was observed
with a lower number of pregnancies w9x. Oxidative stress
in pregnancy, in combination with an activation of the
HPA-axis, may induce micro-damage to maternal arteries
and, therefore, might serve as a possible link between
multigravidity and adverse maternal long term outcome.
However, the mother may not be the only one affected
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by oxidative stress and an activated HPA axis in preg-
nancy, because it was hypothesized that unfavorable
influences during pregnancy can have a long lasting
impact on the unborn baby (Barker9s hypothesis of ‘‘Fetal
Programming’’ w1, 10x). The exact mechanisms respon-
sible for fetal programming are unknown. It has been
proven that women with poor nutrition and a stressful
pregnancy have a greater risk of bearing an underweight
baby that could be affected by the aforementioned dis-
eases w5, 13x. Epidemiological studies on the effect of
severe maternal long term starvation during the Dutch
famine in World War II showed that this is associated with
decreased glucose tolerance and altered endothelial
function in the offspring, especially when they became
obese w13x. However, this association could only be
shown in the Dutch famine study, but not in the Lenin-
grad siege study w21x.
There is overwhelming evidence that suboptimal con-
ditions experienced during intrauterine life could affect
critical fetal systems. Elevated cortisol levels and oxida-
tive stress may be the agents of intrauterine mal-pro-
gramming of endocrine and circulatory regulatory
systems with the consequence of an increased suscep-
tibility for diseases in later life w8, 20x. Oxidative stress in
pregnancy may, therefore, affect the health of mother and
fetus alike.
Important substances for the diagnosis of oxidative
stress are the isoprostanes. They are prostaglandin F2-
like compounds that are generated in vivo in humans by
non-enzymatic free radical-induced peroxidation of ara-
chidonic acid and show high stability w22x. Isoprostanes
have been shown to be elevated in a number of disorders
that are possibly associated with oxidative stress w16x.
One of the major compounds of this group, 8,12-iso-
iPF2a-VI, is a chemically stable, free-radical catalyzed iso-
prostane that reflects lipid peroxidation. After free-radical
attack, it is cleaved from the plasma membrane into the
blood and excreted in the urine. This substance has par-
ticular importance as an indicator of oxidative stress in
vivo.
Interestingly, in our study, metabolic parameters
indicative of catabolism were not elevated in the late sec-
ond trimester in comparison to non-pregnant controls
after a mean fasting time of 12 h. Free fatty acids induce
oxidative stress and, therefore, catabolism is thought to
be a cardiovascular risk factor. Catabolism in our study
is unlikely to be the reason for the elevated oxidative
stress parameters. Metzger et al. w6x described the so-
called ‘‘accelerated starvation’’ after a fasting period of
18 h in the third trimester of pregnancy. After 12 h of
fasting, the results resemble ours in so far that they could
not show catabolic changes in pregnant women. As far
as carbohydrate metabolism is concerned, other studies
found similar results to those found by Metzger et al. with
catabolism and fat mobilization after the first 12 h of star-
vation w11, 14, 18x. Because of ethical reasons, prolon-
gation of the fasting time was not contrivable in our
study.
To the best of our knowledge, this is the first study to
simultaneously examine metabolic parameters charac-
teristic for catabolism, plasma basal cortisol and oxida-
tive stress under standardized conditions in pregnancy.
Each of the three parameters serves as a risk factor for
cardiovascular disease. We were able to show that oxi-
dative stress parameters and cortisol levels are elevated
during normal pregnancy after ‘‘skipping breakfast’’ in
comparison to non-pregnant controls. This elevation is
not accompanied by metabolic signs of starvation. We
hypothesize that the combination of oxidative stress and
an activation of the HPA-axis is the link between the long
term adverse effects of pregnancy (at least in multiparity)
for cardiovascular diseases and (if further increased)
might induce an adverse intrauterine environment that
can have unfavorable and long-lasting effects on the
fetus. Our study, therefore, serves as a theoretical basis
that antioxidants might be useful to prevent long term
adverse effects of multiparity on maternal health.
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